Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-18

Clinical Trial Update: Effect of Moderate Alcohol on Absorption and Onset of Hezkue Sildenafil Suspension [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update assessing how moderate alcohol affects absorption and onset of Hezkue Sildenafil Suspension for erectile dysfunction; status is NO…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hezkue Sildenafil Suspension (sildenafil)

Snippet

Sponsor: Aspargo Labs, Inc | Conditions: Erectile Dysfunction | Phase 2 | Status: NOT_YET_RECRUITING